With a proliferation of new offerings and steady influx of new users, it’s clear that GLP-1 medications are here to stay— but their impact on consumer behavior is rapidly shifting.

On November 12 at 11am CT, join us for an update on the evolving GLP-1 consumer landscape and future considerations for consumer goods companies, featuring a conversation with Terence Flynn, Morgan Stanley Managing Director, Biopharma Research. In a pre-recorded interview, Terence will offer his perspective on the state of the growing GLP-1 market. Numerator experts will then deep dive into the latest wave of our ongoing GLP-1 consumer study to provide insight into:

• The evolving composition of GLP-1 medication users
• Shifting usage intentions and life cycle of use
• How brands and retailers can adapt for long-term success

Speakers:
Mitch Louch – GM, Verified Voices | Numerator
Katya Kazantseva – Senior Consultant | Numerator
Terence Flynn – Managing Director, Biopharma Research | Morgan Stanley